EVGN:NASDAQ
Evogene Ltd
$0.36
arrow_downward
-0.86%(-0.0031) 1D
Nov 3, 10:11:43 AM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EVGN...
Open
$0.36
High
$0.36
Low
$0.35
Mkt. cap
4.88M
Avg. vol.
2.47M
Volume
6.58K
52-wk high
$1.28
52-wk low
$0.35
EPS
-$0.90
Beta
1.45
Shares outstanding
18.05M
No. of employees
52
Open
$0.36
High
$0.36
Low
$0.35
Mkt. cap
4.88M
Avg. vol.
2.47M
Volume
6.58K
52-wk high
$1.28
52-wk low
$0.35
EPS
-$0.90
Beta
1.45
Shares outstanding
18.05M
No. of employees
52
News stories
From web sources and news partners
Local 3 News
·
1 hour ago
RAW: NYSE: OPENING BELL (TUESDAY)
Macau Business
·
44 minutes ago
NYSE-Affiliated Venue for Tokenization Adds Transfer Agents: NYSE Content Update
Bloomberg.com
·
43 minutes ago
Goldman’s Molavi Says 60% of S&P 500 Is in Bear Market Territory
Fox Business
·
1 hour ago
Midterm elections historically trigger S&P 500 gains 100% of the time
Profile
Evogene is a computational chemistry company based in Israel, specializing in the generative design of small molecules for the pharmaceutical and agricultural industries. At the core of its technology is ChemPass AI, a proprietary generative AI engine that enables the design of novel, highly potent small molecules optimized across multiple critical parameters. This powerful platform significantly improves success rates while reducing development time and costs. Built on this powerful technological foundation, and through strategic partnerships alongside internal product development, Evogene is focused on creating breakthrough products driven by the integration of scientific innovation with real-world industry needs.
In 2024, the company began collaborating with Google Cloud to develop an AI-powered generative model aimed at discovering small molecules for drug development and sustainable agriculture. Wikipedia
About Evogene Ltd